Danaher raises full-year guidance as Danaher stock costs EUR 207.00
Published on 10/26/2026 at 11:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSGuidance and operating trends
- Danaher lifted its full-year adjusted earnings guidance to USD 8.57-8.62 on October 21, 2026.
- Core revenue excluding respiratory revenue grew 5.50 percent in the third quarter of 2026.
- Danaher stock traded at EUR 207.00 at 11:23 a.m. CET at Lang & Schwarz on October 26, 2026.
- Danaher's quarterly dividend is payable on October 30, 2026.
Danaher Corp. (ISIN US2358511028) generated USD 6.6 billion in third-quarter 2026 revenue, up 8.50 percent year over year. On October 21, 2026, Danaher raised its full-year adjusted diluted earnings guidance to USD 8.57-8.62 per share from USD 8.45-8.60.
Results strengthen the outlook
The quarter showed a sharper underlying trend beneath the headline sales number. Non-GAAP core revenue excluding respiratory revenue increased 5.50 percent year over year, while total non-GAAP core revenue grew 3.00 percent. Adjusted diluted earnings per share rose 11.50 percent to USD 2.11, according to the October 21 release from Danaher.
Cash conversion also supported the revised outlook. Operating cash flow reached USD 1.9 billion and non-GAAP free cash flow was USD 1.6 billion in the third quarter, while the company expects fourth-quarter core revenue excluding respiratory revenue to grow 4.00 percent to 5.00 percent year over year.
Three events frame the transition
On October 7, 2026, Danaher announced an autonomous laboratory designed to move research from discovery to breakthrough up to 8 times faster, according to Danaher. On October 9, 2026, the company appointed two directors, Daniel L. Comas and Robert Hershberg, to its board, according to Danaher. The October 21 results and guidance increase are the latest event in that sequence.
What does guidance mean?
The revised range points to a higher earnings floor, but respiratory revenue remains a measurable drag. Danaher expects that factor to reduce fourth-quarter core revenue growth by 1.50 percentage points, leaving total core growth near 3.00 percent. The company also expects a fourth-quarter adjusted operating margin of 29.50 percent, making execution and demand outside respiratory testing the key operating variables.
Next dated company event
Danaher's regular quarterly dividend of USD 0.40 per share is payable on October 30, 2026, according to the company's investor-relations release listed on its press-release page.
Stock valuation stays central
Danaher stock had a USD 162.1 billion market capitalization on October 26, 2026. Its USD 160.93 to USD 242.80 52-week range places the latest US-market reference near the upper end of its annual span, while the stronger third-quarter cash flow gives the guidance increase a tangible operating base.
Price at Lang and Schwarz
Danaher was trading at EUR 207.00 at Lang & Schwarz on October 26, 2026, at 11:23 a.m. CET. The latest quote reflects the stock's German-market euro indication during the Xetra session.
The further course of trading is shown by the continuously updated real-time quote of Danaher Corp stock.
Danaher stock key data
- Company: Danaher Corporation
- ISIN: US2358511028
- Ticker: DHR
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 26, 2026, 11:23 a.m. CET): EUR 207.00
- Market capitalization: USD 162.1 billion (as of October 26, 2026)
- 52-week range: USD 160.93-242.80 (as of October 26, 2026)
- Sector / Industry: Healthcare / Diagnostics and Research
- Index membership: S&P 500
Market context: Market report S&P 500.
